|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)
|
12 Months Ended | 60 Months Ended | |
|---|---|---|---|
|
Sep. 30, 2012
|
Sep. 30, 2011
|
Sep. 30, 2012
|
|
| Summary Of Significant Accounting Policies Details Narrative | |||
| Cash balance in excess of FDIC limits | $ 2,382,413 | $ 219,786 | $ 2,382,413 |
| Depreciable life for equipment | 5 years | ||
| Research and development | 1,625,695 | 521,969 | 2,426,215 |
| Research and development expenses approved for reimbursement under grant | $ 179,358 | ||
| Potentially anti-dilutive securities excluded from earnings per share computation | 34,410,090 | 15,574,301 | |
| X | ||||||||||
|
- Definition
The amount of cash deposited in financial institutions as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation (i.e. above FDIC deposit insurance limits). No definition available.
|
| X | ||||||||||
|
- Definition
The amount of research and development expenses incurred during the period that have been approved for reimbursement under grant. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|